R

Rocket Pharmaceuticals

D
RCKT
USD
0.56
(2.6897%)
Market Closed
16,208.00
Volume
-2.466
EPS
-
Div Yield
-7.718412
P/E
1,945,063,865.42
Market Cap
Today
2.6897%
1 Week
12.823%
1 Month
11.238%
6 Months
-20.372%
12 Months
-7.003%
Year To Date
-28.519%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
S
SPCE
-0.11
(-1.6654%)
USD
M
MAXR
(%)
USD
LMT
LMT
-0.58
(-0.1025%)
USD
BA
BA
-0.67
(-0.4317%)
USD
NOC
NOC
0.47
(0.0901%)
USD
A
AJRD
(%)
USD
H
HII
-1.17
(-0.4348%)
USD
E
ETSY
0.09
(0.1667%)
USD
LMT
LMT
-0.58
(-0.1025%)
USD
BA
BA
-0.67
(-0.4317%)
USD

Title:
Rocket Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
Do you need help or have a question?
Contact Us